Rapid and cost-effective drug discovery for resistance-developing diseases.
Machine Translation utilizes computational biology, novel Machine Learning & AI, bioinformatic simulations, and a unique data set to determine which drug candidates will most likely succeed in clinical studies.
Our Services
-
Binformatic Pipelines & Simulations
Bioinformatics pipelines that extract the most information out of NGS that is available. Our bioinformatic simulations can simulate in vitro and generational testing.
-
Advanced AI and Machine Learning
Our AI and Machine Learning algorithms are built to provide insight into how diseases interact with drugs.
-
Unique and Diverse Dataset
Our systems are built and validated using a broad and diverse dataset.
Meet our team
-
Cory Kromer-Edwards, Ph.D.
Founder/CEO
-
Punkaj Ahuja
Commercial Advisor
-
Russ Donda
Business Oversight